Gordon Roble
Papers
1
Total Citations
37
H-Index
1
About
Gordon Roble is a leading researcher in molecular imaging and tumor hypoxia, with a focus on advancing the accuracy of positron emission tomography (PET) for cancer diagnostics. His work centers on validating noninvasive imaging techniques against direct physiological measurements, particularly in the context of oxygen deprivation within tumors. In his highly cited 2012 study, Roble pioneered a rigorous approach to correlating image-guided partial pressure of oxygen (Po₂) probe measurements with parametric images derived from ¹⁸F-fluoromisonidazole small-animal PET data. This work directly addressed longstanding concerns about the reliability of hypoxia imaging by establishing a quantitative link between kinetic PET analysis and ground-truth tissue oxygenation. By demonstrating that dynamic tracer modeling could improve the specificity of hypoxia detection, Roble’s research has provided a critical methodological framework for preclinical and clinical cancer studies. His contributions have been cited over 37 times, reflecting their impact on the field of molecular imaging. Roble’s work continues to shape how researchers interpret PET data, bridging the gap between imaging biomarkers and tumor biology.
Research Focus
Key Achievements
Top Papers
- 1